Answers are grounded in this paper and cite their sources.
In conclusion, obese patients have increased risk for DGF. In the past years, obesity was a risk factor for graft loss, death by CVD, and all-cause mortality. However, for the obese transplanted patient today, the graft and patient survival is the same as that of the nonobese patient.
No takes yet. Share an insight, caveat, or question.
Nicoletto et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: